US Market Report for Dental Bone Graft Substitutes 2017 - MedCore
General Report Contents
Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
Market Drivers & Limiters for each chapter segment
Competitive Analysis for each chapter segment
Section on recent mergers & acquisitions
Though autografts represent a prospective bone graft material option, monetizing their worth is complicated as autograft materials are not purchased. Instead, the autograft market is evaluated separately from the various alternatives that have a price attached to their worth. The allograft market is led by Zimmer Biomet and BioHorizons in the mineralized and DBM spaces. However, a large number of new competitors are also entering this market through private labeling of tissue bank products such as those offered by LifeNet Health.
Dental bone grafting procedures are typically associated with dental implants to restore the edentulous area of a missing tooth. Dental implants require sufficient bone tissue in the jawbone to support the implant and ensure proper integration into the mouth. If a patient has endured being toothless (edentulism) for a prolonged period, they run a high probability of having insufficient bone tissue. In this case, they ideally required a bone graft in order to maximize the outcome of a dental implant surgery.
The bone grafting market is segmented on the basis of the material’s origins. Dental bone graft procedures include autografts, allografts, xenografts and synthetics.